Royalty Pharma plc (RPRX) stock saw a decline, ending the day at $30.3 which represents a decrease of $-0.45 or -1.46% from the prior close of $30.75. The stock opened at $30.79 and touched a low of ...

Wall Street ended last week in positive territory, but it hasn’t been a smooth journey for stocks this year. Markets turned ...

The mean of analysts' price targets for Royalty Pharma (RPRX) points to a 31.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.35% ...

We recently compiled a list of the 14 Best 52-Week High Stocks To Buy According to Analysts. In this article, we are going to ...

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) was the target of unusually large options trading activity on Tuesday. Investors purchased 2,751 call options on the company. This represents an ...

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus rating of “Buy” from the seven ratings firms that ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

TD Cowen analyst Michael Nedelcovych reiterated a Buy rating on Royalty Pharma (RPRX – Research Report) today and set a price target of ...

We recently published an article titled These 10 Firms Led This Week’s Rally. In this article, we are going to take a look at ...

Since its inception in 1996, RP Management has externally controlled and managed Royalty Pharma’s (RPRX) day-to-day ...